Search clinical trials for: Valsartan Hydrochlorothiazide

Total 833 results

Mayo Clinic

Recruiting

PDD in Type 2 Diabetes w/wo Diastolic Dysfunction

Diabetes Mellitus, Type 2 | Diastolic Dysfunction

United States
HealthCore-NERI
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM (VANISH)

Hypertrophic Cardiomyopathy

United States, Canada
Novartis

Terminated

Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH)

Hypertension

United States, Denmark, Finland, Norway, Sweden
Stephen J. Teach, MD, MPH
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Omalizumab Before Onset of Exacerbations (OBOE)

Asthma in Children | Atopy | Viral Upper Respiratory Infection

United States
Universidade Federal Fluminense
Rio de Janeiro State Research Supporting Foundation (FAPERJ)

Completed

Antimicrobial Photodynamic Therapy Associated With the Conventional Endodontic Treatment: A Clinical and Microbiological Study

Infection | Dental Pulp Necrosis | Candida | Polymerase Chain Reaction | Photochemotherapy Reaction | Enterococcal Infections
RenJi Hospital

Recruiting

Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease

Obesity | Chronic Kidney Diseases

China
Vanderbilt University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis

End Stage Renal Failure on Dialysis | Complication of Hemodialysis

United States
An-Najah National University

Recruiting

Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography

Chronic Kidney Diseases | Ischemic Heart Disease | Contrast-induced Nephropathy

Palestinian Territory, occupied
University of Sao Paulo General Hospital

Unknown

The Effect of Diuretics on Mineral and Bone Disorder in Chronic Kidney Disease Patients

Chronic Kidney Disease | Secondary Hyperparathyroidism

Brazil
Novartis Pharmaceuticals

Completed

Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD

Pediatric Hypertension With or Without CKD

Belgium, Poland, Italy, Germany, Guatemala, France, Hungary, Brazil, Lithuania
LaborMed Pharma S.A.

Completed

A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM (AISHA)

Hypertension | Type 2 Diabetes Mellitus

Romania
Novartis

Completed

Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population (ACTION)

Hypertension

United States
Bristol-Myers Squibb

Completed

A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs

HIV Infections

United States
Organon and Co

Completed

HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)

Hypertension | Type 2 Diabetes Mellitus
Pharmtechnology LLC
Altasciences Company, Inc.

Unknown

A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting Conditions

Bioequivalence

Canada
Columbia University

Completed

N-of-1 Trials for Blood Pressure Medications in Adults

Hypertension | High Blood Pressure

United States
IlDong Pharmaceutical Co Ltd

Completed

Clinical Trial to Compare the Pharmacokinetics of TAH Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers

Healthy

Korea, Republic of
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions.

Healthy Subjects
Yonsei University

Completed

Comparison of Beta-blocker Versus Angiotensin Receptor Blocker for Suppression of Aneurysm Expansion in Patients With Small Abdominal Aortic Aneurysm and Hypertension (BASE Trial)

Small Abdominal Aortic Aneurysm

Korea, Republic of
Hospital Moinhos de Vento
Ministry of Health, Brazil; World Stroke Organization

Recruiting

Polipill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE) (PROMOTE)

Stroke | Cognitive Decline

Brazil
Oslo University Hospital
University of Oslo

Completed

Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension (VALUE)

Essential Hypertension
National Cheng-Kung University Hospital
National Science Council, Taiwan

Unknown

Role of Inflammation Factors and Insulin Resistance in Major Depressive Disorder

Major Depressive Disorder

Taiwan
University of Leeds
The Leeds Teaching Hospitals NHS Trust

Completed

Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression

Hypertension | Left Ventricular Hypertrophy

United Kingdom
Mirati Therapeutics Inc.

Terminated

Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
AstraZeneca

Completed

Assessing the Pharmacokinetics of NKTR-118 in Subjects With Renal Impairment Compared to That in Subjects With Normal Renal Function

Renal Impairment

United States
Takeda

Completed

Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension

Hypertension

United States, Mexico, Chile, Peru
University Hospital, Clermont-Ferrand
Hospices Civils de Lyon; University Hospital, Grenoble; Hôpital de la Croix-Rousse and other collaborators

Recruiting

Protocol of Diuretics Use in Congestive Therapy in Heart Failure (ProDUCT-HF)

Heart Failure | Chronic Heart Failure | Acute Heart Failure

France
Creighton University

Completed

Black Education and Treatment of Hypertension (BEAT HTN) (BEAT)

Hypertension

United States
Organon and Co

Completed

SAALT: Subtracting Salt and Adding Losartan Trial (0954A-335)

Hypertension
Boehringer Ingelheim

Completed

Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk Patients

Hypertension

Romania
The George Institute
Byrraju Foundation; The Future Forum, UK

Completed

Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS) (RAPCAPS)

Myocardial Infarction | Diabetes Mellitus | Angina Pectoris | Cerebrovascular Accidents

India
Novartis Pharmaceuticals

Completed

Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension

Essential Hypertension

Taiwan, Japan, Hong Kong, Thailand, Philippines, China, Korea, Republic of
Kyoto Prefectural University of Medicine

Completed

Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)

Stroke | Hypertension | Ischemic Heart Disease | Congestive Heart Failure

Japan
VA New York Harbor Healthcare System

Completed

Night Time Use of Thiazide Diuretics for Improved Reduction in Stone Risk in Stone Formers With Elevated Urine Calcium

Kidney Stones

United States
Swiss Federal Institute of Sport Magglingen

Unknown

Comparison of the Automatized and the Optimized Carbon Monoxid Rebreathing Protocol

Hemoglobins

Switzerland
Novartis Pharmaceuticals

Completed

Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension

Essential Hypertension

Japan
Daiichi Sankyo, Inc.

Completed

The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy Subjects

Healthy
Medical University of Vienna

Not yet recruiting

Dapagliflozin and Hydrochlorothiazide in Recurring Kidney Stone Patients

Urolithiasis | Hyperoxaluria

Austria
Yonsei University

Completed

Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)Hypertension

Essential Hypertension

Korea, Republic of
AstraZeneca
Astra Zeneca, Bristol-Myers Squibb

Completed

Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States, Netherlands, Canada
Second Affiliated Hospital of Nanchang University
Peking University First Hospital

Unknown

Feasibility Study of the Intensive Systolic Blood Pressure Control

Hypertension | Hyperhomocysteinemia

China
University Hospital, Basel, Switzerland
University Hospital, Zürich; University Hospital Freiburg; Krebsforschung Schweiz... and other collaborators

Completed

177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer

Thyroid Cancer, Medullary

Switzerland
Johns Hopkins University

Withdrawn

EBMtrialcentral- Comparing Initial Diuretic Therapies Using a Collaborative Network

Hypertension

United States
William Beaumont Hospitals
Novartis Pharmaceuticals

Withdrawn

Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II Diabetics

Hypertension | Diabetes Type 2

United States
GlaxoSmithKline

Terminated

GSK2251052 in Complicated Urinary Tract Infection

Infections, Urinary Tract

France, United States, Russian Federation, Spain, Greece, Canada
University of Oulu

Completed

Effect of Licorice and Hydrochlorothiazide on Plasma Potassium

Hypokalemia

Finland
Academisch Ziekenhuis Maastricht
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

Timely Recovery After Subclinical Heart Failure (TREASURE)

Heart Failure | Diastolic Dysfunction

Netherlands
Boehringer Ingelheim

Completed

LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib

Carcinoma, Non-Small-Cell Lung

Japan
Yuhan Corporation

Not yet recruiting

Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension

Essential Hypertension

Korea, Republic of
Vanderbilt University

Completed

The SCCS Polypill Pilot Trial

Hypertension | Hyperlipidemia

United States

Search clinical trials for: Valsartan Hydrochlorothiazide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations